The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties.
about
Survey sequencing and comparative analysis of the elephant shark (Callorhinchus milii) genomeThe 2-5A/RNase L/RNase L inhibitor (RLI) [correction of (RNI)] pathway regulates mitochondrial mRNAs stability in interferon alpha-treated H9 cellsInhibition of 2'-5' oligoadenylate synthetase by divalent metal ionsAntiviral actions of interferonsDiverse functions of RNase L and implications in pathologyViral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral responseThe Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate ResponseA nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory miceHost genetic variability and West Nile virus susceptibility.Activation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA.RNase L plays a role in the antiviral response to West Nile virus.The response of mammalian cells to double-stranded RNAInterferon-inducible antiviral effectorsOligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseasesThe interferon alpha induced protein ISG12 is localized to the nuclear membraneMice deficient in oocyte-specific oligoadenylate synthetase-like protein OAS1D display reduced fertilityPassive broad-spectrum influenza immunoprophylaxisGlucocorticoid-attenuated response genes induced in the lung during endotoxemia.Identification and cloning of human polynucleotide phosphorylase, hPNPase old-35, in the context of terminal differentiation and cellular senescence.Type I interferon related genes are common genes on the early stage after vaccination by meta-analysis of microarray data.Mascot file parsing and quantification (MFPaQ), a new software to parse, validate, and quantify proteomics data generated by ICAT and SILAC mass spectrometric analyses: application to the proteomics study of membrane proteins from primary human endoAssociation of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study.Expression and characterization of recombinant 2',5'-oligoadenylate synthetase from the marine sponge Geodia cydonium.Sequence-non-specific effects of RNA interference triggers and microRNA regulators.Whole-genome expression analyses of type 2 diabetes in human skin reveal altered immune function and burden of infection.Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunityInfluenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression.Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanismsGamma interferon triggers interaction between ICSBP (IRF-8) and TEL, recruiting the histone deacetylase HDAC3 to the interferon-responsive element.Molecular Mechanisms of Innate Immune Inhibition by Non-Segmented Negative-Sense RNA Viruses.Adenosine deaminases acting on RNA, RNA editing, and interferon action.Viruses and the type I interferon antiviral system: induction and evasion.Controlling activation of the RNA-dependent protein kinase by siRNAs using site-specific chemical modificationGRIM-1, a novel growth suppressor, inhibits rRNA maturation by suppressing small nucleolar RNAsSelection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2',5'-oligoadenylate synthetase from prostate cancer cellsContrasted patterns of variation and evolutionary convergence at the antiviral OAS1 gene in old world primates.Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.Specificity protein 1 is pivotal in the skin's antiviral response.Impact of IL28B and OAS gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus.Use of attenuated paramyxoviruses for cancer therapy.
P2860
Q21090196-DAB2F133-182A-4240-96FB-EC6C3761AED2Q24291754-E10794DA-75BC-401D-A309-60211FC2DE68Q24291839-85A1B318-7E14-4DB5-8640-E897601F1095Q24550676-1D485F5C-85C0-4DB4-9669-9C2219D2C739Q24652347-DDFEC778-1847-43AB-B06A-71C14A37BD19Q24681387-E84577A6-A317-44DC-BDC2-E65636405629Q26772138-5D86CF22-BEBF-40AC-88A0-B69443745259Q27471916-AD4F3712-2961-4399-B534-056E34CD1FD1Q27472720-5B05272B-E90D-41A5-AE76-AC29374733E5Q27472961-02E36ACD-686C-44AD-B2FB-D1DC78FEBF26Q27473045-4774F493-0517-4D47-9CC1-3DBCD2FEB15EQ27481673-3F6EBF1B-C80E-4C32-B05F-AA0AEDE71269Q27486790-DE67CD14-CDEF-4FA7-BE6E-873EB3F665A7Q28082381-A31952BC-4F5C-447F-8759-15C906F46F40Q28207604-11228B52-73C0-4078-8990-AC8E877BF3ECQ28591624-E69F0E0F-205F-4EBF-9E3C-BA7170D3B150Q30367936-6AD1B2A4-CF33-4CE7-ADB0-350EB4329D1CQ30841886-57B66BC0-C995-4FB4-AF22-23B54E4EB424Q30873494-8867684C-ABA6-4731-996C-D607E1A50F9EQ30922949-ECC48389-8A15-453B-9030-99EFFDFCD8AFQ31113970-A448AF5E-DB6E-4191-A58D-4539E39077ECQ33249075-0A339FEC-EE9C-47A1-8766-4FFA32C0C42CQ33287329-85A12478-06D7-4CAE-AECA-C42B027F5210Q33566425-2995E185-49F6-4D2C-88D8-DF40426780A6Q33798481-A3A0EBD3-1AA1-4E3F-BAC3-9998AE847AE4Q34046869-38752DA5-9956-43AE-A77F-AA1C018912B8Q34057790-966EDD16-AB5D-45FD-B8F2-BF06872E0463Q34142890-701E53BA-1513-4B92-A431-1DEBCF51CF18Q34325633-C94F4FCF-CE11-4AC1-8A45-BC0CD58C0B0EQ34536269-7D2AC210-45F6-42EF-9AAF-EC212F60E265Q34553883-7FD2C7AC-C234-41DF-A7EA-87633C9BCEF5Q35027514-7769B1C5-A93C-4EAA-B3F2-37DD4B848529Q35127967-D4094502-661E-43BD-B469-527BC789C43DQ35204064-BD295546-49B9-48B6-84BC-2DD3F45FFB67Q35545869-8391C148-8538-4CBD-8329-33D3DC51C0A2Q36732659-F32BFA04-8306-4C88-BA8E-F052EE17A071Q37028594-C0E13D5B-1289-4475-8E24-46E419F453F5Q37073740-3FF33071-E077-4E2F-9244-1113A2D157FDQ37411318-E838D4CC-5AC4-463A-B2B3-AE9AFCD1CCF5Q37810599-5ECF4E6C-9560-4EE9-870A-36F7ACF5E29F
P2860
The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The human 2',5'-oligoadenylate ...... h unique enzymatic properties.
@ast
The human 2',5'-oligoadenylate ...... h unique enzymatic properties.
@en
type
label
The human 2',5'-oligoadenylate ...... h unique enzymatic properties.
@ast
The human 2',5'-oligoadenylate ...... h unique enzymatic properties.
@en
prefLabel
The human 2',5'-oligoadenylate ...... h unique enzymatic properties.
@ast
The human 2',5'-oligoadenylate ...... h unique enzymatic properties.
@en
P356
P1476
The human 2',5'-oligoadenylate ...... h unique enzymatic properties.
@en
P2093
A G Hovanessian
D Rebouillat
P304
P356
10.1089/107999099313992
P577
1999-04-01T00:00:00Z